Stocktoria

Cryoport, Inc. CYRX

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2015-07-24 · LEI

Cryoport, Inc. financials (annual)

Revenue
$7.7M $12.0M $19.6M $33.9M $78.7M $222.6M $237.3M $168.7M $156.8M $176.2M 2016201720182019202020212022202320242025
Net income
-$13.1M -$7.9M -$9.6M -$18.3M -$32.7M -$275.5M -$37.3M -$99.6M -$114.8M $78.3M 2016201720182019202020212022202320242025
Free cash flow
-$6.8M -$5.3M -$6.3M -$6.7M -$23.8M -$15.8M -$24.0M -$39.5M -$33.6M -$25.0M 2016201720182019202020212022202320242025

Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$176.2M$156.8M$168.7M$237.3M$222.6M$78.7M$33.9M$19.6M$12.0M$7.7M
Gross profit$83.1M$69.7M$75.3M$103.9M$96.6M$36.3M$17.4M$10.2M$6.0M$3.1M
R&D expense$17.0M$17.7M$18.0M$15.7M$16.8M$9.5M$3.7M$1.8M$1.2M$598,106
SG&A expense$102.8M$109.8M$108.3M$120.1M$97.6M$56.9M$31.3M
Operating income-$36.8M-$121.7M-$100.5M-$31.9M-$17.8M-$30.0M-$17.7M-$8.6M-$7.9M-$8.8M
Interest expense$5.5M$6.1M$4.7M$2.6M$1.4M$69,253$15,693$139,416
Income tax$1.8M$359,000$345,000$2.2M$1.7M-$45,000$62,000$19,954$5,143$5,673
Net income$78.3M-$114.8M-$99.6M-$37.3M-$275.5M-$32.7M-$18.3M-$9.6M-$7.9M-$13.1M
EPS (diluted)$1.40$-2.49$-2.21$-0.93$-6.18$-1.94$-0.55
Operating cash flow-$8.6M-$16.3M-$757,000-$1.9M$8.1M-$14.9M-$1.3M-$3.4M-$3.6M-$5.7M
Free cash flow-$25.0M-$33.6M-$39.5M-$24.0M-$15.8M-$23.8M-$6.7M-$6.3M-$5.3M-$6.8M
Cash & equivalents$250.5M$34.1M$35.2M$29.2M$139.1M$36.9M$47.2M$37.3M$15.0M$4.5M
Inventory$23.2M$21.5M$26.2M$27.7M$16.5M$10.5M$474,000$220,514$114,796$89,499
Total assets$765.0M$703.5M$957.7M$1.0B$1.1B$552.4M$135.9M$56.6M$20.3M$8.1M
Total liabilities$262.4M$301.6M$468.7M$482.9M$471.1M$169.7M$9.6M$18.1M$2.4M$2.4M
Shareholders' equity$502.6M$401.9M$489.0M$555.8M$641.8M$382.7M$126.3M$38.5M$17.9M$5.7M

Growth · year-over-year · Revenue CAGR 41.6%

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue growth+12.4%-7.1%-28.9%+6.6%+182.9%+131.9%+72.9%+64.2%+55.7%+30.5%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.